Revenue Dynamics YoY (Last Twelve Months): Maravai (MRVI)

Brandmark of Maravai (MRVI)

Maravai LifeSciences (MRVI) seeks dominance in the nucleic acids segment by integrating its solutions into gene therapy production cycles. Business stability relies on demand within the biotech sector, which supports margins. The annual revenue growth rate over the trailing four quarters visualizes this trend, where the value 10.60 describes the current level. This confirms the company's role as an indispensable supplier of components for mRNA vaccines.

MRVI Maravai LifeSciences Holdings: Revenue Growth YoY (Last 12 Months) in the range 02/11/2024 - 11/19/2026

Maravai LifeSciences Holdings (MRVI) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Fundamental company valuation:Maravai
Original product of Maravai LifeSciences Holdings, Inc.

Maravai LifeSciences (MRVI) automates nucleic acid synthesis for vaccine development, reducing manual laboratory labor through robotics. This indicator measures the daily dynamics of revenue growth rates on a rolling year basis, allowing investors to assess the speed of business scaling outside of reporting periods by analyzing the year-over-year sales trajectory over the trailing four quarters to verify market demand for high-precision tests.

Competitors of Maravai LifeSciences (MRVI)

Agilent Corp (A) - Trailing Twelve Months Revenue Growth|DGX - Sales Growth YoY (Last Twelve Months)|ILMN: Sales Growth YoY (Last Twelve Months)|EXAS: Sales Growth YoY (TTM)|RVTY (Revvity) - Sales Growth YoY (Last Twelve Months)|BIO (Bio-Rad Laboratories, Inc.) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Anbio Biotechnology NNNN|Revenue Growth YoY (Last 12 Months) SHC (Sotera Health Company)|Sales Growth YoY (Last Twelve Months) QDEL (quidel.com)|Sales Growth YoY (TTM) OPK (opko.com)|Revenue Dynamics YoY (Last Twelve Months) CDNA|FLGT: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) LAB (Fluidigm)|Cytek Biosciences Inc (CTKB) - Sales Growth YoY (Last Twelve Months)|OSUR: Revenue Change YoY (Last 12 Months)|Revenue Growth YoY (Last 12 Months) XGN|MDXH: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Lucid Diagnostics Inc. (LUCD)|Sales Growth YoY (Last Twelve Months) PRE (Prenetics Global Limited)|Sales Growth YoY (TTM) IMDX (Insight Molecular Diagnostics Inc)|Revenue Change YoY (Last 12 Months) TRIB (Trinity Biotech Corp)|PRPH - Sales Growth YoY (Last Twelve Months)|Ainos (AIMD) - Revenue Growth YoY (Last 12 Months)|CoDx (CODX) - Sales Growth YoY (Last Twelve Months)|HSCS (Heart Test Labs) - Sales Growth YoY (Last Twelve Months)|BMRA (Biomerica, Inc.) - Sales Growth YoY (TTM)|CDIO (Cardio Diagnostics) - Revenue Change YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) Onconetix Corp (ONCO)|VRAX (Virax Biolabs Group Limited) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BJDX (Bluejay Diagnostics Corp)|Aspira Women's Health - Sales Growth YoY (Last Twelve Months)|AXDX - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Centogene NV (CNTG)|ENZ (Enzo Biochem) - Revenue Growth YoY (Last 12 Months)|fresh2.co (FRES) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) Genetic Technologies Limited|Trailing Twelve Months Revenue Growth 23andMe Inc. ME|Sales Growth YoY (Last Twelve Months) Psychemedics (PMD)